Immunologic Action of a Single Dose Cholecalciferol
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
Vitamin D receptors are expressed in activated different immune cells. It is not known, which
immune cell type is targeted by exogenous vitamin D. Here, vitamin D-deficient individuals
will receive once 100.000 I.U. vitamin D3 either intramuscular or subcutaneous in a
double-blind placebo controlled setting. Immune cells will be monitored from the blood over
time.
Phase:
Phase 4
Details
Lead Sponsor:
Margitta Worm
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins